R.PR
REGISTERED-PRINCIPAL REGISTER
10/26/2021
Back to search
Official data from USPTO
USSF US SPECIALTY FORMULATIONS LLC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
10/26/2021
Trademark type
Combined
Nice classes
1, 5
Filing date
08/05/2020
Registration date
10/26/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/26/2021
Last transaction
10/26/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/15/2013
First use in commerce
04/03/2015
Drawing code
3
Owner type
16
Owner location
Allentown, PA
Examiner
YOUNG, THOMAS PAUL
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a shield with a concave top coming to a point in each corner. An elongated curved line narrowing to a point at each end that crosses the front of the shield and curves around the back of the shield. "USSF" to the right of the shield. "US SPECIALTY FORMULATIONS LLC" is to the right of the shield and below "USSF".
Holders and representatives
Holders
US Specialty Formulations LLC
Representatives
Thomas J Bordner PRINCE LOBEL TYE LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Active bulk chemical ingredients for use in the manufacture of pharmaceuticals for treating or preventing diseases in humans and animals; adjuvants for use in the manufacture of vaccines
Class 5
Pharmaceutical preparations for use in ophthalmologyoncologysteroidal replacement therapyfor regulating the immune system; injectable pharmaceuticals for use in ophthalmologyoncologysteroidal replacement therapyfor regulating the immune system; plant extracts for medicalveterinary and pharmaceutical purposes; chemical reagents for medical and veterinary diagnostic purposes
Publications
History of USPTO decisions and trademark events.
19 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/10/2021
PUBO
PUBLISHED FOR OPPOSITION
08/10/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/21/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/01/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
06/02/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/02/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
06/02/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/01/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/01/2020
GNRT
NON-FINAL ACTION E-MAILED
12/01/2020
CNRT
NON-FINAL ACTION WRITTEN
12/01/2020
DOCK
ASSIGNED TO EXAMINER
11/24/2020
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/05/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/04/2020
NWAP
NEW APPLICATION ENTERED
08/08/2020
Continuous trademark protection
Get notified about every new filing that threatens USSF US SPECIALTY FORMULATIONS LLC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.